Navigation Links
West Haven Firm Expands Biomedical Disposal Program with Community Economic Development Fund
Date:5/14/2010

MERIDEN, Conn., May 14 /PRNewswire/ -- Connecticut waterways may be safer from biomedical waste, thanks to an innovative Community Economic Development Fund small business loan guarantee program. CEDF, with loan-program partners, Connecticut's Department of Economic and Community and the City of West Haven have guaranteed a small business loan to a West Haven company that stems improper disposal of needles and prescription drugs.

West Haven's Pathacura removes area medical waste from health care facilities safely and with a dedication to protecting one of the state's most precious assets, its water. "Pharmaceuticals and personal health care products in the water are a growing national concern; it's important that Connecticut's water is protected from pollutants and chemicals," says Pathacura's Michael Monsillo.

Monsillo's father started Pathacura 15 years ago. The son's been growing the business despite difficult economic conditions. Even as the recession deepened, Pathacura's volume spiked with H1N1 testing and vaccinations. "Pathacura's credit needed development, but we were too small a company to go to a bank for funding," he says.

Monsillo heard about CEDF's micro-finance loan guarantee program at a Rotary Club meeting. CEDF, with the Department of Economic and Community Development and cities of Hartford, Stamford, Bridgeport and West Haven, created the program to mitigate the risk of eligible small businesses. The cities support the small loans with 30 percent guarantees. The program is also partially funded by the Small Business Administration.

Pathacura is using the loan to expand its medical hazardous remediation work for local businesses and public facilities.

"The guarantee programs with our partners enhance CEDF's ability to support small business, particularly start-up or at-risk business and those with little or no collateral," says Donna Wertenbach, CEDF President and CEO. She noted that CEDF can make these loans because 21 banks and other institutions have invested in CEDF's small business, high-risk loan pool.

CEDF was created in 1994 to revitalize Connecticut's distressed neighborhoods by providing greater access to capital, technical assistance to small businesses and support for community economic development. Since then CEDF has provided millions of dollars in loans to small businesses, created and retained thousands of jobs for the state's residents, and funded numerous community planning efforts. Joining forces with the state, leading lenders and representatives from low and moderate income communities, CEDF is helping Connecticut's small businesses and neighborhoods.


'/>"/>
SOURCE CEDF
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Biodel Inc. Expands Ongoing Phase III VIAject(TM) Clinical Trials Into Europe
2. BiPar Expands Management Team to Advance Lead PARP Inhibitor Product Candidate Into Phase 2 Trials for Cancer
3. Cellectar Expands Clinical Management Team
4. VIA Pharmaceuticals Expands Clinical Trial Program for VIA-2291 in Acute Coronary Syndrome
5. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
6. Millennium Expands VELCADE(R) (Bortezomib) For Injection Program In Non-Hodgkins Lymphoma
7. PAREXEL Expands Global Clinical Pharmacology Capabilities
8. BiPar Sciences Expands Clinical Program for BSI-201, a Novel DNA Repair Inhibitor, in Brain Cancer
9. Senesco Expands on Recently Announced Preclinical Pancreatic Islet Data
10. Alseres Pharmaceuticals Expands Sites for the First Stage of the ALTROPANE(R) Phase III Clinical Trial Program
11. Delcath Expands Phase III Trial for Metastatic Melanoma to Include University of Maryland Medical Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... 8, 2016  Labvantage Lx, a newcomer to ... male sexual enhancement product, EnduramenT. Setting a new ... with a patented biomedical breakthrough molecule that promotes ... compound responsible for many biological functions including erectile ... Forgoing the use of prescription medications, scientists ...
(Date:2/8/2016)... , Feb. 8, 2016  Echo Therapeutics, ... device company focused on non-invasive continuous glucose ... today announced that it will host a ... 17, 2015 at 9:00 a.m. Eastern Time ... its corporate strategy, advancements in its CGM ...
(Date:2/8/2016)... 2016 In a historic vote among its members this weekend, ... medical cannabis cultivation facility and dispensary on tribal land near ... as a provider for patients in the state,s Medical Cannabis Program. ... a provider for patients in the state,s Medical Cannabis Program. ... the project and pursue designation from the State of New ...
Breaking Medicine Technology:
(Date:2/8/2016)... Houma, LA (PRWEB) , ... February 08, 2016 ... ... Louisiana from offices in Houma, LA, celebrates the beginning of a new charity ... raised to assist Court Appointed Special Advocates (CASA). In the belief that children ...
(Date:2/8/2016)... ... ... If you are feeling that your clothes are a tad snug, the ... Center for Disease Control and Prevention (CDC), 34.9% of U.S. adult women are overweight. ... some of the leading causes of preventable death. February is heart health month ...
(Date:2/8/2016)... FL (PRWEB) , ... February 08, 2016 , ... ... new community enrichment program serving the greater Venice, FL area, has initiated a ... tragically in a car accident just four days after Christmas. To support this ...
(Date:2/8/2016)... ... 08, 2016 , ... Eating disorders and post-traumatic stress disorder ... and men with eating disorders report a history of trauma, research suggests that ... an eating disorder. , At the 2016 iaedp Symposium, the workshop, “What ...
(Date:2/8/2016)... MD (PRWEB) , ... February 08, 2016 , ... ... is excited to share this important news! AHCC and the Home Health and ... Coding Clinic, CMS' designee for official ICD coding guidance and clarifications, to address ...
Breaking Medicine News(10 mins):